Your browser doesn't support javascript.
loading
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study.
Murphy, M E; Wills, G H; Murthy, S; Louw, C; Bateson, A L C; Hunt, R D; McHugh, T D; Nunn, A J; Meredith, S K; Mendel, C M; Spigelman, M; Crook, A M; Gillespie, S H.
Afiliação
  • Murphy ME; UCL Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, England, UK. michael.murphy@ucl.ac.uk.
  • Wills GH; MRC Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, Aviation House, 125 Kingsway, London, WC2B 6NH, England, UK.
  • Murthy S; UCL Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, England, UK.
  • Louw C; Madibeng Centre for Research, Brits, South Africa.
  • Bateson ALC; Department of Family Medicine, School of medicine, University of Pretoria, Pretoria, South Africa.
  • Hunt RD; UCL Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, England, UK.
  • McHugh TD; UCL Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, England, UK.
  • Nunn AJ; UCL Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, England, UK.
  • Meredith SK; MRC Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, Aviation House, 125 Kingsway, London, WC2B 6NH, England, UK.
  • Mendel CM; MRC Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, Aviation House, 125 Kingsway, London, WC2B 6NH, England, UK.
  • Spigelman M; Global Alliance for Tuberculosis Drug Development, New York, NY, 10005, USA.
  • Crook AM; Global Alliance for Tuberculosis Drug Development, New York, NY, 10005, USA.
  • Gillespie SH; MRC Clinical Trials Unit at UCL, Institute for Clinical Trials and Methodology, Aviation House, 125 Kingsway, London, WC2B 6NH, England, UK.
BMC Med ; 16(1): 189, 2018 10 17.
Article em En | MEDLINE | ID: mdl-30326959
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article